Gilead Sciences, Inc. (GILD)
151.22
+1.61
(+1.08%)
USD |
NASDAQ |
Sep 03, 16:00
150.02
-1.20
(-0.79%)
Pre-Market: 09:12
Gilead Sciences Cash and Short Term Investments (Quarterly) : 4.882B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.882B |
| March 31, 2026 | 9.817B |
| December 31, 2025 | 9.613B |
| September 30, 2025 | 9.175B |
| June 30, 2025 | 6.523B |
| March 31, 2025 | 9.13B |
| December 31, 2024 | 11.57B |
| September 30, 2024 | 6.697B |
| June 30, 2024 | 4.198B |
| March 31, 2024 | 6.059B |
| December 31, 2023 | 8.35B |
| September 30, 2023 | 7.974B |
| June 30, 2023 | 7.098B |
| March 31, 2023 | 6.266B |
| December 31, 2022 | 6.858B |
| September 30, 2022 | 6.238B |
| June 30, 2022 | 5.663B |
| March 31, 2022 | 5.325B |
| December 31, 2021 | 7.405B |
| September 30, 2021 | 6.609B |
| June 30, 2021 | 6.844B |
| March 31, 2021 | 6.463B |
| December 31, 2020 | 8.261B |
| September 30, 2020 | 24.96B |
| June 30, 2020 | 19.36B |
| Date | Value |
|---|---|
| March 31, 2020 | 21.02B |
| December 31, 2019 | 24.67B |
| September 30, 2019 | 23.15B |
| June 30, 2019 | 28.37B |
| March 31, 2019 | 29.01B |
| December 31, 2018 | 30.95B |
| September 30, 2018 | 29.30B |
| June 30, 2018 | 26.58B |
| March 31, 2018 | 24.68B |
| December 31, 2017 | 26.14B |
| September 30, 2017 | 29.07B |
| June 30, 2017 | 21.61B |
| March 31, 2017 | 14.71B |
| December 31, 2016 | 11.90B |
| September 30, 2016 | 12.27B |
| June 30, 2016 | 8.752B |
| March 31, 2016 | 8.319B |
| December 31, 2015 | 14.61B |
| September 30, 2015 | 15.71B |
| June 30, 2015 | 8.611B |
| March 31, 2015 | 11.29B |
| December 31, 2014 | 10.13B |
| September 30, 2014 | 6.316B |
| June 30, 2014 | 8.799B |
| March 31, 2014 | 6.469B |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 7.863B |
| AbbVie, Inc. | 6.569B |
| Regeneron Pharmaceuticals, Inc. | 8.005B |
| Amgen, Inc. | 13.99B |
| Biogen, Inc. | 1.285B |